ALPS Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22M | Sell |
40,220
-12,754
| -24% | -$705K | 0.01% | 353 |
|
|
2025
Q1 | $2.56M | Sell |
52,974
-2,967
| -5% | -$143K | 0.01% | 312 |
|
|
2024
Q4 | $2.16M | Buy |
55,941
+3,909
| +8% | +$151K | 0.01% | 339 |
|
|
2024
Q3 | $2.34M | Buy |
52,032
+6,260
| +14% | +$282K | 0.02% | 335 |
|
|
2024
Q2 | $1.59M | Buy |
45,772
+4,673
| +11% | +$162K | 0.01% | 373 |
|
|
2024
Q1 | $1.19M | Buy |
41,099
+1,027
| +3% | +$29.7K | 0.01% | 433 |
|
|
2023
Q4 | $919K | Sell |
40,072
-2,377
| -6% | -$54.5K | 0.01% | 503 |
|
|
2023
Q3 | $708K | Buy |
42,449
+368
| +0.9% | +$6.14K | 0.01% | 550 |
|
|
2023
Q2 | $1.16M | Buy |
42,081
+9,666
| +30% | +$267K | 0.01% | 443 |
|
|
2023
Q1 | $746K | Sell |
32,415
-934
| -3% | -$21.5K | 0.01% | 523 |
|
|
2022
Q4 | $364K | Buy |
33,349
+6,528
| +24% | +$71.2K | ﹤0.01% | 717 |
|
|
2022
Q3 | $226K | Sell |
26,821
-2,048
| -7% | -$17.3K | ﹤0.01% | 986 |
|
|
2022
Q2 | $228K | Sell |
28,869
-20,891
| -42% | -$165K | ﹤0.01% | 976 |
|
|
2022
Q1 | $1.18M | Sell |
49,760
-5,472
| -10% | -$130K | 0.01% | 294 |
|
|
2021
Q4 | $1.89M | Buy |
+55,232
| New | +$1.89M | 0.02% | 295 |
|
|
2018
Q2 | – | Sell |
-27,468
| Closed | -$236K | – | 963 |
|
|
2018
Q1 | $236K | Buy |
27,468
+4,774
| +21% | +$41K | ﹤0.01% | 828 |
|
|
2017
Q4 | $472K | Buy |
+22,694
| New | +$472K | ﹤0.01% | 607 |
|